Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Sees Large Decline in Short Interest

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) was the target of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 646,100 shares, a drop of 16.6% from the March 15th total of 774,400 shares. Currently, 3.1% of the company’s stock are short sold. Based on an average daily trading volume, of 1,040,000 shares, the days-to-cover ratio is presently 0.6 days.

Ekso Bionics Stock Performance

NASDAQ:EKSO opened at $0.42 on Monday. The firm has a market capitalization of $12.25 million, a PE ratio of -0.65 and a beta of 1.33. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. The stock’s 50-day simple moving average is $0.45 and its 200 day simple moving average is $0.65. Ekso Bionics has a twelve month low of $0.34 and a twelve month high of $1.53.

Ekso Bionics (NASDAQ:EKSO) last released its quarterly earnings results on Monday, March 3rd. The company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.07) by ($0.07). Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. The firm had revenue of $5.09 million for the quarter, compared to the consensus estimate of $5.05 million. On average, analysts anticipate that Ekso Bionics will post -0.48 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. HC Wainwright reissued a “buy” rating and issued a $9.00 price objective on shares of Ekso Bionics in a research report on Tuesday, March 4th. StockNews.com assumed coverage on Ekso Bionics in a research report on Sunday. They set a “hold” rating on the stock. Finally, Lake Street Capital decreased their price target on shares of Ekso Bionics from $2.00 to $1.00 and set a “buy” rating on the stock in a research note on Tuesday, March 4th.

About Ekso Bionics

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.